Hospital/patient management
Last updated: 2025 Jun 18
Total hit(s): 15944
S.No.
1
39701925
COVID-19 vaccine knowledge and acceptance among the Libyan population: A cross-sectional study.
Hum Vaccin Immunother
2025 Dec
4.7
1
2
39882841
Exploring the association between happy hypoxia and Coronavirus disease 2019 in the triage phase.
Future Sci OA
2025 Dec
3.25
1
3
40358138
Detection of S1 spike protein in CD16+ monocytes up to 245 days in SARS-CoV-2-negative post-COVID-19 vaccine syndrome (PCVS) individuals.
Hum Vaccin Immunother
2025 Dec
4.7
1
4
39898697
Acceptance and attitudes towards COVID-19 vaccination during pregnancy in Canada.
Hum Vaccin Immunother
2025 Dec
4.7
1
5
40497727
The effect of SARS-CoV-2 and influenza vaccination on endemic coronavirus-related mortality: A retrospective cohort study in Brazil.
Hum Vaccin Immunother
2025 Dec
4.7
1
6
40338231
Assessing vaccine coverage and delivery strategies for influenza and COVID-19 among Italian healthcare workers: A 2015-2023 case study.
Hum Vaccin Immunother
2025 Dec
4.7
1
7
39763233
Changes in seasonal influenza vaccination uptake among older adults during and after the COVID-19 pandemic: Repeated random telephone surveys.
Hum Vaccin Immunother
2025 Dec
4.7
1
8
40382672
The double burden of stressful life events among professional nurses: public mass shootings during the COVID-19 pandemic.
Int J Qual Stud Health Well-being
2025 Dec
1
9
40382340
Increased dialysis symptom index burden in maintenance hemodialysis patients during the COVID-19 lockdown period.
Ann Med
2025 Dec
3.01
1
10
39729392
COVID-19 vaccine acceptance and preference for future delivery among language minority, newcomer, and racialized peoples in Canada: a national cross-sectional and longitudinal study.
Ann Med
2025 Dec
3.01
1
11
39720838
Immunogenicity and safety of SARS-CoV-2 recombinant protein vaccine (CHO cell) LYB001 as a heterologous booster following two- or three-dose inactivated COVID-19 vaccine in adults aged >/=18 years: interim results of a randomized, active-controlled, double-blinded, phase 3 trial.
Expert Rev Vaccines
2025 Dec
4.37
1
12
40135763
Growing attention of immunogenicity among patients with autoimmune diseases post-SARS-CoV-2 vaccination: meta-analysis and systematic reviews of the current studies.
Ann Med
2025 Dec
3.01
1
13
40134119
Gaps in vaccine clinical trials in Africa: A mixed scoping review and bibliometric analysis before, during, and post- COVID-19 pandemic.
Hum Vaccin Immunother
2025 Dec
4.7
1
14
40156199
COVID-19 vaccine hesitancy in Chinese residents: A national cross-sectional survey in the community setting.
Hum Vaccin Immunother
2025 Dec
4.7
1
15
40152750
Long-term alveolar-capillary diffusion impairments after severe SARS-CoV-2 pneumonia.
Ann Med
2025 Dec
3.01
1
16
40366666
A four-week study on the toxicity of repeated intramuscular administration of plant-based BA-CoV2-0301 vaccine against SARS-CoV-2 in Sprague-Dawley rats.
J Immunotoxicol
2025 Dec
1
17
39699990
Hemostatic changes following COVID-19 vaccination: Do they promote a pro-thrombotic state?
Hum Vaccin Immunother
2025 Dec
4.7
1
18
40376714
Efficacy, immunogenicity, and safety of heterologous boosting with a novel chimera Chinese mRNA (RQ3013) SARS-CoV-2 vaccine: A randomized, double-blind, active-controlled trial.
Hum Vaccin Immunother
2025 Dec
4.7
1
19
40411306
Antibody-dependent enhancement of SARS-CoV-2, the impact of variants and vaccination.
Hum Vaccin Immunother
2025 Dec
4.7
1
20
40028815
Impact of FcRn antagonism on vaccine-induced protective immune responses against viral challenge in COVID-19 and influenza mouse vaccination models.
Hum Vaccin Immunother
2025 Dec
4.7
1
21
40214651
From Wuhan to Omicron K.P2 strain: A comprehensive review of SARS-CoV-2 phylogeny and public health implications of the latest booster vaccine.
Hum Vaccin Immunother
2025 Dec
4.7
1
22
40195167
Safety profile of self-amplifying mRNA SARS-CoV-2 vaccine ARCT-154 in adults: a pooled phase 1/2/3 randomized clinical study.
Expert Rev Vaccines
2025 Dec
4.37
1
23
40407705
T-cell responses to highly conserved SARS-CoV-2 epitopes in Hispanic Americans receiving an mRNA COVID-19 vaccine.
Hum Vaccin Immunother
2025 Dec
4.7
1
24
40179339
Attitudes and beliefs regarding COVID-19 and COVID-19 Omicron booster vaccine among adults in the vaccine safety datalink, 2022-2023.
Hum Vaccin Immunother
2025 Dec
4.7
1
25
40381203
Safety and immunogenicity of SARS-CoV-2 protein subunit recombinant vaccine (Indovac(R)) in healthy populations aged 18 years and above in Indonesia: A phase I, observer-blind, randomized, controlled study.
Hum Vaccin Immunother
2025 Dec
4.7
1